vs
Side-by-side financial comparison of HAEMONETICS CORP (HAE) and OUTFRONT Media Inc. (OUT). Click either name above to swap in a different company.
OUTFRONT Media Inc. is the larger business by last-quarter revenue ($513.3M vs $339.0M, roughly 1.5× HAEMONETICS CORP). OUTFRONT Media Inc. runs the higher net margin — 18.9% vs 13.2%, a 5.7% gap on every dollar of revenue. On growth, OUTFRONT Media Inc. posted the faster year-over-year revenue change (4.1% vs -2.7%). OUTFRONT Media Inc. produced more free cash flow last quarter ($93.3M vs $87.2M). Over the past eight quarters, OUTFRONT Media Inc.'s revenue compounded faster (12.1% CAGR vs 0.4%).
Haemonetics Corporation is a global provider of blood and plasma supplies and services. The company was founded in Natick, Massachusetts by Dr. Allen (Jack) Latham in the 1970s.
Outfront Media, Inc. is an American advertising company. It operates in the United States. The Americas division is led by chief executive officer Nick Brien. Outfront Media has both billboards and transit displays.
HAE vs OUT — Head-to-Head
Income Statement — Q3 FY2026 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $339.0M | $513.3M |
| Net Profit | $44.7M | $96.8M |
| Gross Margin | 59.7% | — |
| Operating Margin | 19.9% | 26.0% |
| Net Margin | 13.2% | 18.9% |
| Revenue YoY | -2.7% | 4.1% |
| Net Profit YoY | 19.3% | 30.8% |
| EPS (diluted) | $0.95 | $0.57 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $339.0M | $513.3M | ||
| Q3 25 | $327.3M | $467.5M | ||
| Q2 25 | $321.4M | $460.2M | ||
| Q1 25 | $330.6M | $390.7M | ||
| Q4 24 | $348.5M | $493.2M | ||
| Q3 24 | $345.5M | $451.9M | ||
| Q2 24 | $336.2M | $477.3M | ||
| Q1 24 | — | $408.5M |
| Q4 25 | $44.7M | $96.8M | ||
| Q3 25 | $38.7M | $51.3M | ||
| Q2 25 | $34.0M | $19.5M | ||
| Q1 25 | $58.0M | $-20.6M | ||
| Q4 24 | $37.5M | $74.0M | ||
| Q3 24 | $33.8M | $34.6M | ||
| Q2 24 | $38.4M | $176.8M | ||
| Q1 24 | — | $-27.2M |
| Q4 25 | 59.7% | — | ||
| Q3 25 | 59.5% | — | ||
| Q2 25 | 59.8% | — | ||
| Q1 25 | 58.4% | — | ||
| Q4 24 | 55.5% | — | ||
| Q3 24 | 54.2% | — | ||
| Q2 24 | 52.0% | — | ||
| Q1 24 | — | — |
| Q4 25 | 19.9% | 26.0% | ||
| Q3 25 | 17.9% | 19.2% | ||
| Q2 25 | 16.8% | 12.2% | ||
| Q1 25 | 21.6% | 3.6% | ||
| Q4 24 | 16.9% | 22.5% | ||
| Q3 24 | 15.0% | 15.8% | ||
| Q2 24 | 11.8% | 48.0% | ||
| Q1 24 | — | 3.4% |
| Q4 25 | 13.2% | 18.9% | ||
| Q3 25 | 11.8% | 11.0% | ||
| Q2 25 | 10.6% | 4.2% | ||
| Q1 25 | 17.5% | -5.3% | ||
| Q4 24 | 10.8% | 15.0% | ||
| Q3 24 | 9.8% | 7.7% | ||
| Q2 24 | 11.4% | 37.0% | ||
| Q1 24 | — | -6.7% |
| Q4 25 | $0.95 | $0.57 | ||
| Q3 25 | $0.81 | $0.29 | ||
| Q2 25 | $0.70 | $0.10 | ||
| Q1 25 | $1.17 | $-0.14 | ||
| Q4 24 | $0.74 | $0.49 | ||
| Q3 24 | $0.66 | $0.19 | ||
| Q2 24 | $0.74 | $1.01 | ||
| Q1 24 | — | $-0.18 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $363.4M | $99.9M |
| Total DebtLower is stronger | $1.2B | — |
| Stockholders' EquityBook value | $911.5M | $710.4M |
| Total Assets | $2.5B | $5.3B |
| Debt / EquityLower = less leverage | 1.34× | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $363.4M | $99.9M | ||
| Q3 25 | $296.4M | $63.0M | ||
| Q2 25 | $292.9M | $28.5M | ||
| Q1 25 | $306.8M | $30.5M | ||
| Q4 24 | $320.8M | $46.9M | ||
| Q3 24 | $299.3M | $28.0M | ||
| Q2 24 | $344.4M | $49.6M | ||
| Q1 24 | — | $42.4M |
| Q4 25 | $1.2B | — | ||
| Q3 25 | $1.2B | — | ||
| Q2 25 | $1.2B | — | ||
| Q1 25 | $1.2B | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | $911.5M | $710.4M | ||
| Q3 25 | $849.2M | $542.6M | ||
| Q2 25 | $882.3M | $539.1M | ||
| Q1 25 | $820.8M | $566.9M | ||
| Q4 24 | $906.9M | $649.0M | ||
| Q3 24 | $878.9M | $618.2M | ||
| Q2 24 | $905.4M | $664.9M | ||
| Q1 24 | — | $524.2M |
| Q4 25 | $2.5B | $5.3B | ||
| Q3 25 | $2.4B | $5.2B | ||
| Q2 25 | $2.5B | $5.1B | ||
| Q1 25 | $2.5B | $5.1B | ||
| Q4 24 | $2.5B | $5.2B | ||
| Q3 24 | $2.5B | $5.2B | ||
| Q2 24 | $2.5B | $5.3B | ||
| Q1 24 | — | $5.5B |
| Q4 25 | 1.34× | — | ||
| Q3 25 | 1.44× | — | ||
| Q2 25 | 1.39× | — | ||
| Q1 25 | 1.49× | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $93.6M | $118.1M |
| Free Cash FlowOCF − Capex | $87.2M | $93.3M |
| FCF MarginFCF / Revenue | 25.7% | 18.2% |
| Capex IntensityCapex / Revenue | 1.9% | 4.8% |
| Cash ConversionOCF / Net Profit | 2.09× | 1.22× |
| TTM Free Cash FlowTrailing 4 quarters | $308.1M | $218.8M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $93.6M | $118.1M | ||
| Q3 25 | $111.3M | $88.8M | ||
| Q2 25 | $17.4M | $67.1M | ||
| Q1 25 | $116.6M | $33.6M | ||
| Q4 24 | $43.8M | $124.5M | ||
| Q3 24 | $48.8M | $73.1M | ||
| Q2 24 | $-27.4M | $71.0M | ||
| Q1 24 | — | $30.6M |
| Q4 25 | $87.2M | $93.3M | ||
| Q3 25 | $106.3M | $67.7M | ||
| Q2 25 | $13.6M | $41.4M | ||
| Q1 25 | $100.9M | $16.4M | ||
| Q4 24 | $35.2M | $106.3M | ||
| Q3 24 | $39.4M | $55.5M | ||
| Q2 24 | $-33.1M | $47.1M | ||
| Q1 24 | — | $12.2M |
| Q4 25 | 25.7% | 18.2% | ||
| Q3 25 | 32.5% | 14.5% | ||
| Q2 25 | 4.2% | 9.0% | ||
| Q1 25 | 30.5% | 4.2% | ||
| Q4 24 | 10.1% | 21.6% | ||
| Q3 24 | 11.4% | 12.3% | ||
| Q2 24 | -9.8% | 9.9% | ||
| Q1 24 | — | 3.0% |
| Q4 25 | 1.9% | 4.8% | ||
| Q3 25 | 1.5% | 4.5% | ||
| Q2 25 | 1.2% | 5.6% | ||
| Q1 25 | 4.7% | 4.4% | ||
| Q4 24 | 2.5% | 3.7% | ||
| Q3 24 | 2.7% | 3.9% | ||
| Q2 24 | 1.7% | 5.0% | ||
| Q1 24 | — | 4.5% |
| Q4 25 | 2.09× | 1.22× | ||
| Q3 25 | 2.88× | 1.73× | ||
| Q2 25 | 0.51× | 3.44× | ||
| Q1 25 | 2.01× | — | ||
| Q4 24 | 1.17× | 1.68× | ||
| Q3 24 | 1.44× | 2.11× | ||
| Q2 24 | -0.71× | 0.40× | ||
| Q1 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
HAE
| Hospital | $143.5M | 42% |
| Plasma Productsand Services | $138.9M | 41% |
| Blood Center Productsand Services | $56.6M | 17% |
OUT
| Static Displays | $236.3M | 46% |
| Other | $134.8M | 26% |
| Digital Displays | $125.3M | 24% |
| Other Revenues | $1.9M | 0% |
